Characteristics of Patients With Type 2 Diabetes Mellitus (CVD-RNDR)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-15

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This observational retrospective study will describe characteristics of patients with type 2 diabetes mellitus (T2DM) who were initiating use or treatment with sodium-glucose co-transporter-2 (SGLT-2) inhibitors and other diabetes medications (other glucose lowering drugs) in 2015-17 based on National Russian Diabetes Registry data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study With Dapagliflozin

NCT02971618

Diabetes Mellitus Type 2

COMPLETED

Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)

NCT03249506

Diabetes Mellitus, Type 2

COMPLETED

Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes

NCT02397421

Heart Failure Diabetes

COMPLETED PHASE4

Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure

NCT03741972

Heart Failure

COMPLETED

A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

NCT03492580

Diabetes Mellitus, Type 2 Cardiovascular Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* New user receiving or dispensed prescription of SGLT-2 inhibitor medication or other GLD treatments oral as well as injectable, including fixed-dose combination (FDC) products containing these medication groups;
* T2DM diagnosis on or prior to the index year;
* ≥ 18 years old at index year.

Exclusion Criteria

* Patients with a T1DM diagnosis on or prior to index year and only insulin use in the year prior to index;
* Patients with a gestational diabetes in the index year or 1 year prior to index.

Eligible Sex

ALL

Accepts Healthy Volunteers

No